Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- The latest revision is v3.4.2, replacing v3.4.1 in the history. This appears to be a minor maintenance update with no change to study data or content.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page history.SummaryDifference0.1%

- Check47 days agoChange DetectedMinor site release update from Revision: v3.3.3 to v3.3.4; this change does not affect study data, content, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedFooter area updated: removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' and added 'Revision: v3.3.3'.SummaryDifference0.2%

- Check97 days agoChange DetectedThe Record History now includes a new revision entry v3.3.2 and removes v3.2.0, reflecting a routine update to the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange DetectedThe government funding/operating status notice banner was removed from the page.SummaryDifference0.6%

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.